SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036191
Filing Date
2020-11-10
Accepted
2020-11-10 16:33:37
Documents
54
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_hoththerapeutics.htm 10-Q 425149
2 CERTIFICATION f10q0920ex31-1_hoththera.htm EX-31.1 13666
3 CERTIFICATION f10q0920ex31-2_hoththera.htm EX-31.2 13536
4 CERTIFICATION f10q0920ex32-1_hoththera.htm EX-32.1 5276
5 CERTIFICATION f10q0920ex32-2_hoththera.htm EX-32.2 5299
  Complete submission text file 0001213900-20-036191.txt   2926187

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE hoth-20200930.xml EX-101.INS 401650
7 XBRL SCHEMA FILE hoth-20200930.xsd EX-101.SCH 52893
8 XBRL CALCULATION FILE hoth-20200930_cal.xml EX-101.CAL 26587
9 XBRL DEFINITION FILE hoth-20200930_def.xml EX-101.DEF 198746
10 XBRL LABEL FILE hoth-20200930_lab.xml EX-101.LAB 367652
11 XBRL PRESENTATION FILE hoth-20200930_pre.xml EX-101.PRE 207793
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38803 | Film No.: 201301639
SIC: 2834 Pharmaceutical Preparations